A recently launched campaign starring patients and scientists shows Sanofi in hot pursuit of scientific innovation. | A ...

Sanofi’s stock narrative is shifting as analysts revise their consensus price target slightly downward, from $106.90 to $106.85. This minor adjustment reflects a careful reassessment of Sanofi’s ...

Sanofi is rolling out a new global campaign that features the stories of six real patients, to underscore its core purpose.

Sanofi's “Badge of Honor,” made with FCB Health New York, won gold for Data-Driven Campaign of the Year among suppliers, ...

Sanofi reported stronger than expected third-quarter profit on Friday, boosted by demand for blockbuster asthma drug Dupixent, even as the French drugmaker flagged lower vaccination rates partly due ...

Sanofi Consumer Healthcare India Limited ( ($IN:SANOFICONR) ) just unveiled an update. Sanofi Consumer Healthcare India Limited announced the ...

Sanofi successfully prices USD 3billion of bond issue Paris, France – October 28, 2025 - Sanofi announces that it has successfully priced its ...

The pharmaceutical company Sanofi reduced the supply of influenza vaccines to Ukraine by 60% in the current epidemic season - ...

Sanofi is narrowing development of one of its 5 billion euro ($5.4 billion), “pipeline-in-a-product” assets. The French drugmaker axed Sjögren’s syndrome from the list of targeted indications for ...

The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organization (CDSCO), has approved ...

Sanofi’s ‘A Trusted Circle,’ made with Republica Havas Health, won bronze for Purpose-led Campaign of the Year among ...

Sanofi remporte cette année la palme du champion climatique du CAC40, selon une analyse réalisée par Les Ateliers du futur.